These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 11920752)
1. New and better protocols for a short-term Caco-2 cell culture system. Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752 [TBL] [Abstract][Full Text] [Related]
2. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Behrens I; Kissel T Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294 [TBL] [Abstract][Full Text] [Related]
3. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. Lentz KA; Hayashi J; Lucisano LJ; Polli JE Int J Pharm; 2000 Apr; 200(1):41-51. PubMed ID: 10845684 [TBL] [Abstract][Full Text] [Related]
4. In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. Bravo SA; Nielsen CU; Amstrup J; Frokjaer S; Brodin B Eur J Pharm Sci; 2004 Jan; 21(1):77-86. PubMed ID: 14706814 [TBL] [Abstract][Full Text] [Related]
5. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells. Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278 [TBL] [Abstract][Full Text] [Related]
6. Development, validation, and application of a novel 7-day Caco-2 cell culture system. Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865 [TBL] [Abstract][Full Text] [Related]
7. 3D-fibroblast tissues constructed by a cell-coat technology enhance tight-junction formation of human colon epithelial cells. Matsusaki M; Hikimoto D; Nishiguchi A; Kadowaki K; Ohura K; Imai T; Akashi M Biochem Biophys Res Commun; 2015 Feb; 457(3):363-9. PubMed ID: 25576862 [TBL] [Abstract][Full Text] [Related]
8. An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes. Tavelin S; Taipalensuu J; Hallböök F; Vellonen KS; Moore V; Artursson P Pharm Res; 2003 Mar; 20(3):373-81. PubMed ID: 12669956 [TBL] [Abstract][Full Text] [Related]
9. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier. Dunkoksung W; Vardhanabhuti N; Jianmongkol S J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430 [TBL] [Abstract][Full Text] [Related]
10. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539 [TBL] [Abstract][Full Text] [Related]
11. Studies on intestinal absorption of sulpiride (1): carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2. Watanabe K; Sawano T; Terada K; Endo T; Sakata M; Sato J Biol Pharm Bull; 2002 Jul; 25(7):885-90. PubMed ID: 12132663 [TBL] [Abstract][Full Text] [Related]
12. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells. Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369 [TBL] [Abstract][Full Text] [Related]
13. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media. Ranaldi G; Consalvo R; Sambuy Y; Scarino ML Toxicol In Vitro; 2003; 17(5-6):761-7. PubMed ID: 14599474 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Hosoya KI; Kim KJ; Lee VH Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427 [TBL] [Abstract][Full Text] [Related]
15. In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients. Berginc K; Žakelj S; Kristl A Eur J Nutr; 2010 Sep; 49(6):373-84. PubMed ID: 20140680 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers. Foster DR; Landowski CP; Zheng X; Amidon GL; Welage LS Pharmacol Res; 2009 Mar; 59(3):215-20. PubMed ID: 19084598 [TBL] [Abstract][Full Text] [Related]
17. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines. Li Q; Sai Y; Kato Y; Tamai I; Tsuji A Pharm Res; 2003 Aug; 20(8):1119-24. PubMed ID: 12948007 [TBL] [Abstract][Full Text] [Related]
18. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Batrakova EV; Li S; Miller DW; Kabanov AV Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers. Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]